RTsafe Featured in Forbes

21February 2019

The Forbes article discusses RTsafe’s growth and how the company enhances the safety and efficiency in radiotherapy for brain cancer.

Click here to read the full article.

Explore our Products
& Services

13May 2026
Webinar - End-to-End dosimetry audit for SRS/SBRT: Optional or mandatory at the beginning of the journey?
Read More
12May 2026
RTsafe welcomes Dr Penny Kechagioglou to its Board of Directors
Read More

Request a quote

×

If you are a patient press here to see our dedicated site.

«